PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Higher-dose RT results in inferior survival in patients with stage III lung cancer

2013-05-30
(Press-News.org) In a randomized phase III clinical trial conducted by the Radiation Therapy Oncology Group (RTOG), high-dose (HD), compared with standard-dose (SD), radiotherapy (RT) with concurrent chemotherapy (CT) did not improve overall survival of patients with stage III non-small-cell lung cancer (NSCLC).

Philadelphia, PA—Of all the patients in the US with lung cancer, the country's leading cause of cancer death, 75 to 80 percent of them have NSCLC, with 30 to 40 percent of those being considered locally advanced (stage IIIA or IIIB). Although RT plus CT has been the standard of care for locally advanced NSCLC, more research has focused on the incorporation of appropriate CT drugs than on revisiting the 60-Gy RT dose established over 30 years ago. Concern over local tumor progression rates near 85 percent following treatment for stage III NSCLC with CT plus conventional RT doses and research results showing increased median survival time associated with a 74-Gy RT dose led to the development of RTOG 0617, which sought to identify the optimal RT dose for the treatment of patients with locally advanced NSCLC. The trial additionally tested the hypothesis that the addition of cetuximab, a drug that targets the epidermal growth factor receptor (EGFR) pathway and has radiation-sensitizing properties, to chemoradiation would lead to improved survival.

The trial randomized 464 patients with pathologically diagnosed unresectable stage IIIA or IIIB NSCLC to SD (60 Gy) or HD (74 Gy) arms. All patients received concurrent CT of weekly paclitaxel and carboplatin, as well as additional cycles of consolidation CT following combined CT and RT.

The trial's final results on radiation dose will be presented Tuesday, June 4 at the American Society of Clinical Oncology 2013 Annual Meeting by Principal Investigator (PI) Jeffrey D. Bradley, M.D., a professor in radiation oncology, and chief of thoracic service at Washington University School of Medicine in St. Louis, Mo. Median follow-up time of the trial's 419 evaluable patients was 17.2 months, with a median survival time of 28.7 vs. 19.5 months and 18-month overall survival rates of 66.9% vs. 53.9% for the SD and HD arms, respectively. Local failure rates at 18 months similarly favored the SD over the HD arms. "In the setting of concurrent chemotherapy with daily radiation therapy for stage III lung cancer, these results definitively confirm that 60 Gray is superior to 74 Gray, with a clear detriment associated with the higher radiation dose," concludes Bradley. Although participants were stratified according to the RT technique used (three-dimensional vs. intensity- modulated RT [IMRT]), analysis of survival, patterns of failure, and physician-reported toxicity did not identify one technique to be better or worse than the other, according to Bradley.

Bradley points to two emerging research directions that benefit from the knowledge gained by the RTOG 0617 trial. "With the identification of a number of genetic driver mutations, targeted therapy is clearly the next phase of treatment for NSCLC," states Bradley. RTOG 1306 is an example of a phase II study evaluating newly developed agents that block EGFR or anaplastic lymphoma kinase (ALK) mutations. "Patients will receive either a targeted agent for a few months followed by chemoradiation or chemoradiation alone, which represents the standard arm in RTOG 0617," he explains.

A second research direction addresses how to improve RT in the setting of concurrent CT with the efficacy of the lower RT dose now confirmed. According to Bradley, efforts will focus on evaluating the use of adaptive RT, which involves changing the radiation treatment plan delivered to a patient during a course of RT. In RTOG 1106 protocol, for example, a patient on the experimental arm undergoes a PET scan after 20 RT treatments, and the RT plan is then refocused on the remaining tumor volume, with a higher dose per fraction given for the remaining 10 treatments."

"These results stand as an excellent example of the importance of rigorously testing new radiotherapy strategies and of RTOG's essential role in conducting clinical trials to provide the evidence to guide clinical care," says Walter J. Curran, Jr. M.D., RTOG Group Chair and Executive Director of the Winship Cancer Institute of Emory University in Atlanta.

###

The Radiation Therapy Oncology Group (RTOG) is administered by the American College of Radiology (ACR) and located in the ACR Center for Clinical Research in Philadelphia, PA. RTOG is a multi-institutional international clinical cooperative group funded primarily by National Cancer Institute grants CA21661, CA32115 and CA37422. RTOG has 40 years of experience in conducting clinical trials and is comprised of over 300 major research institutions in the United States, Canada and internationally. The group currently is currently accruing to 40 studies that involve radiation therapy alone or in conjunction with surgery and/or chemotherapeutic drugs or which investigate quality of life issues and their effects on the cancer patient. The American College of Radiology (ACR) is a national professional organization serving more than 32,000 radiologists, radiation oncologists, interventional radiologists and medical physicists with programs focusing on the practice of radiology and the delivery of comprehensive health care services.

http://www.rtog.org

END



ELSE PRESS RELEASES FROM THIS DATE:

Stanford scientists develop high-efficiency zinc-air battery

2013-05-30
Stanford University scientists have developed an advanced zinc-air battery with higher catalytic activity and durability than similar batteries made with costly platinum and iridium catalysts. The results, published in the May 7 online edition of the journal Nature Communications, could lead to the development of a low-cost alternative to conventional lithium-ion batteries widely used today. "There have been increasing demands for high-performance, inexpensive and safe batteries for portable electronics, electric vehicles and other energy storage applications," said Hongjie ...

Organic polymers show sunny potential

2013-05-30
A new version of solar cells created by laboratories at Rice and Pennsylvania State universities could open the door to research on a new class of solar energy devices. The photovoltaic devices created in a project led by Rice chemical engineer Rafael Verduzco and Penn State chemical engineer Enrique Gomez are based on block copolymers, self-assembling organic materials that arrange themselves into distinct layers. They easily outperform other cells with polymer compounds as active elements. The discovery is detailed online in the American Chemical Society journal Nano ...

Californians with 'medical home' more likely to get flu shots, preventive treatment

2013-05-30
Too many cooks may spoil a recipe, and too many doctors may give you the flu. That's the takeaway from a new study by the UCLA Center for Health Policy Research that found that Californians who jump from provider to provider rather than seeing a regular doctor who coordinates their care may be less likely to get the kind of preventive treatment that protects against the flu and flare ups in their chronic conditions. Specifically, the study used data from the 2009 California Health Interview Survey (CHIS) to estimate whether the approximately 4.76 million California ...

Task master: Categorizing rewards improves motivation

2013-05-30
What truly inspires individuals to perform at their very best? When it comes to motivating others and ourselves, it turns out offering rewards in defined categories, even when they are largely meaningless, can heighten motivation. According to recent research co-authored by Scott S. Wiltermuth, assistant professor of management and organization at USC's Marshall School of Business, even if the rewards are the similar – and the categories arbitrary – the very act of segmenting rewards motivates people to perform better and longer, even on menial tasks. Wiltermuth's study, ...

Living in poor area as teen could increase risk for chlamydia in young adulthood

2013-05-30
COLUMBUS, Ohio – Living in a poor neighborhood as an adolescent is linked to an increased risk of getting the sexually transmitted infection (STI) chlamydia in young adulthood, according to new research. Ohio State University researchers analyzed data from a large national study that tracked youths over time. The analysis suggested that children who lived in poor neighborhoods during their teenage years had an almost 25 percent greater risk of having chlamydia in their early 20s – even if they themselves weren't poor – than did teenagers living in wealthier settings. The ...

From trauma to tau

2013-05-30
University of Texas Medical Branch at Galveston researchers have uncovered what may be a key molecular mechanism behind the lasting damage done by traumatic brain injury. The discovery centers on a particular form of a protein that neuroscientists call tau, which has also been associated with Alzheimer's disease and other neurodegenerative conditions. Under ordinary conditions, tau is essential to neuron health, but in Alzheimer's the protein aggregates into two abnormal forms: so-called "neurofibrillary tangles," and collections of two, three, or four or more tau units ...

NASA's Swift reveals new phenomenon in a neutron star

2013-05-30
Astronomers using NASA's Swift X-ray Telescope have observed a spinning neutron star suddenly slowing down, yielding clues they can use to understand these extremely dense objects. A neutron star is the crushed core of a massive star that ran out of fuel, collapsed under its own weight, and exploded as a supernova. A neutron star can spin as fast as 43,000 times per minute and boast a magnetic field a trillion times stronger than Earth's. Matter within a neutron star is so dense a teaspoonful would weigh about a billion tons on Earth. This neutron star, 1E 2259+586, ...

Artificial sweeteners may do more than sweeten

2013-05-30
AUDIO: Artificial sweeteners are thought to make foods and drinks taste sweet without any of the other consequences that come from sugar. But now studying people who are obese, nutrition researchers... Click here for more information. Researchers at Washington University School of Medicine in St. Louis have found that a popular artificial sweetener can modify how the body handles sugar. In a small study, the researchers analyzed the sweetener sucralose (Splenda®) in 17 ...

Study helps explain growing education gap in mortality among US white women

2013-05-30
WASHINGTON, DC, May 28, 2013 — Less-educated white women were increasingly more likely to die than their better-educated peers from the mid-1990s through the mid-2000s, according to a new study, which found that growing disparities in economic circumstances and health behaviors—particularly employment status and smoking habits—across education levels accounted for an important part of the widening mortality gap. "Based on the information we get from the news, it seems that life expectancy just keeps going up, and we're all riding this wave," said Jennifer Karas Montez, ...

Labor union decline, not computerization, main cause of rising corporate profits

2013-05-30
WASHINGTON, DC, May 28, 2013 — A new study suggests that the decline of labor unions, partly as an outcome of computerization, is the main reason why U.S. corporate profits have surged as a share of national income while workers' wages and other compensation have declined. The study, "The Capitalist Machine: Computerization, Workers' Power, and the Decline in Labor's Share within U.S. Industries," which appears in the June issue of the American Sociological Review, explores an important dimension of economic inequality that has been largely overlooked in research and ...

LAST 30 PRESS RELEASES:

New study reveals young, active patients who have total knee replacements are unlikely to need revision surgery in their lifetime

Thinking outside the box: Uncovering a novel approach to brainwave monitoring

Combination immunotherapy before surgery may increase survival in people with head and neck cancer

MIT engineers turn skin cells directly into neurons for cell therapy

High sugar-sweetened beverage intake and oral cavity cancer in smoking and nonsmoking women

Area socioeconomic status, vaccination access, and female HPV vaccination

Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment

CityUHK researchers develop an innovative bio-detection platform for cancer early screening and disease monitoring

English translation of harnessing data for improved productivity: managing the full life cycle of data licensed at the London Book Fair

COVID-19 discovery opens door to new treatments for chronic lung problems

Stanford Medicine research explores the promise and perils of AI in citizen science

New approaches to tackle coupled urban risks: a people-centric and complex systems perspective

OFC conference to showcase energy-efficient optical links that result in faster, low-power photonic chips

Ultra-low dose CT aids pneumonia diagnosis in immunocompromised patients

US bird populations continue alarming decline, new report finds

RSV hospitalization risk among older adults linked to age and certain risk conditions

Co-authored USF study identifies ‘surprising’ cause of sargassum blooms in Caribbean

Statins, aspirin may impact muscle health in smokers

Retiring abroad puts older adults at risk for loneliness, study finds

Insilico Medicine secures $110 million Series E financing to advance AI and robotics- driven drug discovery innovation

Researchers at Case Western Reserve University identify RNA molecule as possible driver of gastric cancer

ENDO 2025 opens media registration

Study: ‘Sustainable intensification’ on the farm reduces soil nitrate losses, maintains crop yields

A closer look at severe tricuspid regurgitation in AFMR patients

Watching nature scenes can reduce pain, new study shows

Scientists from IOCB Prague are on track of finding a treatment for autoimmune hair loss

Literary theorist Gayatri Chakravorty Spivak named 2025 Holberg Prize Laureate

The relationship between gut microbiota, immunoglobulin A, and vaccine efficacy

Advancing sorghum science: drought-resilient crop for Spain's agricultural future

Round up, just below, or precise amount? Choosing the final price of a product may be just a cultural thing

[Press-News.org] Higher-dose RT results in inferior survival in patients with stage III lung cancer